PharmaVoice ١٠ مارس ٢٠٢٦ Executives want in, but researchers want out — how pharma’s US job picture is changing
PharmaVoice ٩ مارس ٢٠٢٦ The first KRAS drugs have been sluggish on the market. Will the next generation fare better?
PharmaVoice ٣ مارس ٢٠٢٦ J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks